National Health (Pharmaceutical Benefits) Regulations (Amendment) (Cth)
REGULATIONS UNDER THE NATIONAL HEALTH ACT-1953.*
WHEREAS
it is provided by sub-section 101 (4) of the
AND WHEREAS that Committee has recommended to the
Minister that the following drugs and medicinal preparations be prescribed as
pharmaceutical benefits under section 85 of the
NOW THEREFORE I, THE GOVERNOR-GENERAL of the
Commonwealth of Australia, acting with the advice of the Federal Executive
Council, hereby make the following Regulations under the
Dated this twenty fifth day of July, 1977
Governor-General.
By His Excellency’s Command,
(Sgd. Ralph J. Hunt)
Minister of State for Health.
_______
Amendments of the National Health (Pharmaceutical Benefits) Regulations
_________________________________________________________________________________
* Notified in the
Statutory Rules 1960, No. 17 as amended
to date. For previous amendments of the National Health (Pharmaceutical Benefits) Regulations
13860/77 Cat. No. —Recommended retail price 60c 12/18.7.1977
SCHEDULE 1 Sub-regulations 10 (1) and (2)
Drugs and Medicinal Preparations in the British Pharmacopoeia that are not to be supplied as or, except as specially provided, used in pharmaceutical benefits
1 Acetarsol | 63 Carbachol Injection |
2 Acetomenaphthone | 64 Carbamazepine |
3 Acetomenaphthone Tablets | 65 Carbenoxolone Sodium |
4 Acetrizoic Acid | 66 Carbimazole |
5 Alcohol, Dehydrated | 67 Carbomer |
6 Alcohol (95%) | 68 Carbon Dioxide |
7 Allopurinol | 69 Carbromal |
8 Almond Oil | 70 Cardamom Fruit |
9 Aloes | 71 Cascara |
10 Alprenolol Hydrochloride | 72 Cascara Dry Extract |
11 Aluminium Glycinate | 73 Cascara Liquid Extract |
12 Aluminium Hydroxide Tablets | 74 Cascara Tablets |
13 Aluminium Phosphate Gel | 75 Castor Oil |
14 Aluminium Phosphate Gel, Dried | 76 Catgut, Sterilised Surgical |
15 Aluminium Phosphate Tablets | 77 Cellulose, Oxidised |
16 Amethocaine Hydrochloride | 78 Cetomacrogol 1000 |
17 Amodiaquine Tablets | 79 Cetylpyridinium Chloride |
18 Amphetamine Sulphate | 80 Chlorambucil |
19 Amphetamine Sulphate Tablets | 81 Chlorcyclizine Hydrochloride |
20 Amylobarbitone Sodium Tablets | 82 Chlordiazepoxide Capsules |
21 Antazoline Hydrochloride | 83 Chlordiazepoxide Hydrochloride |
22 Antazoline Tablets | 84 Chlorhexidine Gluconate Solution |
23 Anti-D (Rho) Immunoglobulin Injection | 85 Chlorhexidine Hydrochloride |
24 Antimony Sodium Tartrate | 86 Chlormerodrin
( |
25 Antimony Sodium Tartrate Injection | 87 Chloroform |
26 Apomorphine Hydrochloride | 88 Chloroquine Phosphate Injection |
27 Apomorphine Injection | 89 Chloroquine Sulphate |
28 Arachis Oil | 90 Chlorothiazide |
29 Aspirin and Caffeine Tablets | 91 Chlorotrianisene |
30 Aspirin and Codeine Tablets | 92 Chlorotrianisene Capsules |
31 Aspirin and Codeine Tablets, Soluble | 93 Chlorphenesin |
32 Aspirin, Phenacetin and Codeine Tablets | 94 Chlorpheniramine Injection |
33 Aspirin, Phenacetin and Codeine Tablets, | 95 Chlorproguanil Hydrochloride |
Soluble | 96 Chlorproguanil Tablets |
34 Azathioprine | 97 Chlorpropamide |
35 Bacillus Calmette-Guérin Vaccine | 98 Chlorthalidone |
36 Barbitone Sodium | 99 Choline Theophyllinate Tablets |
37 Barbitone Sodium Tablets | 100 Cinchocaine Hydrochloride |
38 Barium Sulphate | 101 Cinnamon |
39 Belladonna Dry Extract | 102 Clofibrate |
40 Belladonna Herb | 103 Clomiphene Citrate |
41 Bendrofluazide | 104 Clomiphene Tablets |
42 Benzhexol Hydrochloride | 105 Cochineal |
43 Benzyl Alcohol | 106 Cod-liver Oil |
44 Benzylpenicillin Tablets | 107 Colchicine |
45 Betamethasone Sodium Phosphate Tablets | 108 Colchicum Corm |
46 Bethanidine Sulphate | 109 Colchicum Liquid Extract |
47 Biperiden | 112 Colophony |
48 Bisacodyl Tablets | 113 Concentrated Peppermint Water |
49 Bupivacaine Hydrochloride | 114 Coriander |
50 Busulphan | 115 Coriander Oil |
51 Butobarbitone | 116 Corticotrophin |
52 Butylated Hydroxyanisole | 117 Corticotrophin Injection |
53 Butylated Hydroxytoluene | 118 Corticotrophin Gelatin Injection |
54 Caffeine Hydrate | 119 Corticotrophin Zinc Injection |
55 Calciferol Solution | 120 Cortisone Acetate |
56 Calcium Aminosalicylate | 121 Cortisone Injection |
57 Calcium Gluconate Injection | 122 Cresol |
58 Calcium Lactate | 123 Crotamiton |
59 Calcium Lactate Tablets | 124 Cyanocobalamin |
60 Camphor | 125
Cyanocobalamin ( |
61 Candicidin | 126
Cyanocobalamin ( |
62 Caraway |
Schedule 1—
127 Cyclobarbitone Calcium | 194 Domiphen Bromide | |
128 Cyclomethycaine Sulphate | 195 Dothiepin Capsules | |
129 Cyclopenthiazide | 196 Dothiepin Hydrochloride | |
130 Cyclopentolate Hydrochloride | 197 Dried Human Albumin | |
131 Cyclopropane | 198 Dydrogesterone | |
132 Cycloserine | 199 Dydrogesterone Tablets | |
133 Cycloserine Tablets | 200 Edrophonium Chloride | |
134 Dapsone | 201 Edrophonium Injection | |
135 Demeclocycline Hydrochloride | 202 Eltor Vaccine | |
136 Deoxycortone Acetate | 203 Emetine and Bismuth Iodide | |
137 Deoxycortone Acetate Implants | 204 Emetine Hydrochloride | |
138 Deoxycortone Acetate Injection | 205 Emetine Injection | |
139 Dequalinium Acetate | 206 Erythromycin Estolate Capsules | |
140 Dequalinium Chloride | 207 Ethacrynic Acid | |
141 Desipramine Hydrochloride | 208 Ethambutol Hydrochloride | |
142 Dexamphetamine Sulphate | 209 Ethambutol Tablets | |
143 Dextran 110 Injection | 210 Ethchlorvynol | |
144 Dextromethorphan Hydrobromide | 211 Ethchlorvynol Capsules | |
145 Dextromethorphan Tablets | 212 Ether Anaesthetic | |
146 Dextropropoxyphene Capsules | 213 Ether Solvent | |
147 Dextropropoxyphene Napsylate | 214 Ethionamide | |
148 Dextrose | 215 Ethionamide Tablets | |
149 Diamorphine Hydrocloride | 216 Ethisterone | |
150 Diamorphine Injection | 217 Ethisterone Tablets | |
151 Diazepam Capsules | 218 Ethopropazine Hydrochloride | |
152 Diazoxide | 219 Ethotoin | |
153 Diazoxide Tablets | 220 Ethotoin Tablets | |
154 Dibromopropamidine Isethionate | 221 Ethyl Chloride | |
155 Dichloralphenazone | 222 Ethyloestrenol | |
156 Dichloralphenazone Tablets | 223 Ethyl Oleate | |
157 Dichlorophen | 224 Ethylenediamine Hydrate | |
158 Dichlorophen Tablets | 225 Eucalyptus Oil | |
159 Dichlorphenamide | 226 Eugenol | |
160 Dicophane | 227 Fenfluramine Hydrochloride | |
161 Dicyclomine Tablets | 228 Fenfluramine Tablets | |
162 Diethylcarbamazine Citrate | 229 Ferric
Citrate ( | |
163 Diethylcarbamazine Tablets | 230 Ferrous Fumarate | |
164 Diethyltoluamide | 231 Ferrous Succinate | |
165 Digitalis Leaf | 232 Ferrous Succinate Capsules | |
166 Digitalis, Prepared | 233 Ferrous Succinate Tablets | |
167 Digitalis Tablets, Prepared | 234 Ferrous Sulphate Tablets | |
168 Digitoxin | 235 Fludrocortisone Acetate | |
169 Digitoxin Tablets | 236 Flufenamic Acid | |
170 Digoxin Paediatric Injection | 237 Flufenamic Acid Capsules | |
171 Dihydrocodeine Injection | 238 Fluorescein Sodium | |
172 Dihydrocodeine Tablets | 239 Fluoxymesterone | |
173 Di-iodohydroxyquinoline Tablets | 240 Fluphenazine Decanoate | |
174 Diloxanide Furoate | 241 Fluphenazine Enanthate | |
175 Dilute Alcohols | 242 Fractionated Coconut Oil | |
176 Dimenhydrinate | 243 Fractionated Palm Kernel Oil | |
177 Dimenhydrinate Injection | 244 Frusemide | |
178 Dimenhydrinate Tablets | 245 Gallamine Injection | |
179 Dimercaprol | 246 Gallamine Triethiodide | |
180 Dimethisterone | 247 Gelatin Sponge, Absorbable | |
181 Dimethisterone Tablets | 248 Gentamicin Sulphate | |
182 Dimethyl Phthalate | 249 Gentian | |
183 Dimethyl Sulphoxide | 250 Ginger | |
184 Diodone Injection | 251 Glibenclamide | |
185 Diphenhydramine Injection | 252 Globin Zinc Insulin Injection | |
186 Diphtheria Vaccine | 253 Glucagon | |
187 Diphtheria and Tetanus Vaccine | 254 Glutethimide | |
188 Diphtheria, Tetanus and Pertussis Vaccine | 255 Glutethimide Tablets | |
189 Diphtheria, Tetanus and Poliomyelitis Vaccine | 256 Gold ( | |
190 Diphtheria, Tetanus, Pertussis and Poliomyelitis Vaccine | 257 Griseofulvin | |
191 Dipipanone Hydrochloride | 258 Guanethidine Monosulphate | |
192 Dipipanone Injection | 259 Halibut-liver Oil | |
193 Dodecyl Gallate | 260 Halibut-liver Oil Capsules | |
261 Halothane | ||
262 Halquinol | ||
263 Helium | ||
Schedule 1—
264 Heparin | 324 Levorphanol Tablets |
265 Hexachlorophane | 325 Levorphanol Tartrate |
266 Hexylresorcinol | 326 Lignocaine and Adrenaline Injection |
267 Histamine Acid Phosphate | 327 Lincomycin Capsules |
268 Histamine Acid Phosphate Injection | 328 Liothyronine Sodium |
269 Human Albumin | 329 Liquorice |
270 Human Albumin Fraction (Saline) | 330 Lithium Carbonate |
271 Human Albumin Fraction (Saline), | 331 Lymecycline |
Dried | 332 Lymecycline and Procaine Injection |
272 Human Antihaemophilic Fraction, | 333 Lymecycline Capsules |
Dried | 334 Macrosalb ( |
273 Human Antitetanus Immunoglobulin | 335 Macrogol 300 |
Injection | 336 Macrogol 1540 |
274 Human Antivaccinia Immunoglobulin Injection | 337 Macrogol 4000 |
275 Human Blood, Whole | 338 Magnesium Stearate |
276 Human Fibrinogen, Dried | 339 Maize Oil |
277 Human Fibrinogen for Isotopic Labelling, | 340 Male Fern |
Dried | 341 Male Fern Extract |
278 Human Normal Immunoglobulin | 342 Maleic Acid |
Injection | 343 Mannitol |
279 Human Plasma, Dried | 344 Measles Vaccine (Live Attenuated) |
280 Human Red Blood Corpuscles, | 345 Mefenamic Acid |
Concentrated | 346 Mefenamic Acid Capsules |
281 Human Serum, Dried | 347 Megestrol Acetate |
282 Human Thrombin, Dried | 348 Meglumine |
283 Hydrocortisone Hydrogen Succinate | 349 Meglumine Diatrizoate Injection |
284 Hydrocortisone Ointment | 350 Meglumine Iothalamate Injection |
285 Hydroflumethiazide | 351 Melarsoprol Injection |
286 Hydroxocobalamin | 352 Melphalan |
287 Hydroxychloroquine Sulphate | 353 Melphalan Injection |
288 Hydroxyprogesterone Hexanoate | 354 Mepacrine Hydrochloride |
289 Hydroxyprogesterone Injection | 355 Mepacrine Tablets |
290 Hyoscine Injection | 356 Mephentermine Injection |
291 Hyoscine Eye Ointment | 357 Mephentermine Sulphate |
292 Hyoscine Tablets | 358 Meprobamate |
293 Hyoscyamus | 359 Meprobamate Tablets |
294 Ibuprofen | 360 Mepyramine Injection |
295 Indigo Carmine | 361 Mepyramine Maleate |
296 Indomethacin | 362 Mepyramine Tablets |
297 Influenza Vaccine | 363 Mercaptopurine |
298 Influenza Vaccine, Adsorbed | 364 Mersalyl Acid |
299 Industrial Methylated Spirit | 365 Mersalyl Injection |
300 Intracutaneous Typhoid-paratyphoid | 366 Metaraminol Injection |
A & B Vaccine | 367 Metaraminol Tartrate |
301 Inulin | 368 Methacycline Hydrochloride |
302 Inulin Injection | 369 Methandienone |
303 Iodinated ( | 370 Methaqualone |
Injection | 371 Methisazone |
304 Iodinated ( | 372 Methisazone Mixture |
Injection | 373 Methohexitone Injection |
305 Iodipamide Meglumine | 374 Methoin |
Injection | 375 Methoserpidine |
306 Iodised Oil Fluid Injection | 376 Methoserpidine Tablets |
307 Iopanoic Acid | 377 Methoxyflurane |
308 Iopanoic Acid Tablets | 378 Methylamphetamine Hydrochloride |
309 Iophendylate Injection | 379 Methylamphetamine Injection |
310 Iothalamic Acid | 380 Methylamphetamine Tablets |
311 Ipecacuanha | 381 Methylcellulose 450 |
312 Ipecacuanha, Prepared | 382 Methyldopa |
313 Isocarboxazid | 383 Methyldopate Hydrochloride |
314 Isocarboxazid Tablets | 384 Methyldopate Injection |
315 Isoniazid | 385 Methylergometrine Injection |
316 Isopropyl Alcohol | 386 Methylergometrine Maleate |
317 Kanamycin Acid Sulphate | 387 Methylprednisolone Tablets |
318 Kanamycin Sulphate | 388 Methylthiouracil |
319 Laevulose | 389 Methylthiouracil Tablets |
320 Laevulose Injection | 390 Methyprylone |
321 Lemon Peel, Dried | 391 Methyprylone Tablets |
322 Levallorphan Injection | 392 Metronidazole |
323 Levorphanol Injection | 393 Metyrapone |
Schedule 1—
394 Metyrapone Capsules | 463 Phenmetrazine Tablets | |
395 Morphine Sulphate Tablets | 464 Phenobarbitone Sodium Tablets | |
396 Nalorphine Hydrobromide | 465 Phenol and Glycerol Injection | |
397 Nandrolone Decanoate | 466 Phenolphthalein Tablets | |
398 Nandrolone Phenylpropionate | 467 Phenoxybenzamine Capsules | |
399 Neostigmine Bromide | 468 Phenoxybenzamine Hydrochloride | |
400 Nialamide | 469 Phenoxymethylpenicillin | |
401 Nialamide Tablets | 470 Phenoxymethylpenicillin Calcium | |
402 Niclosamide | 471 Phenoxymethylpenicillin Potassium | |
403 Nicotinamide | 472 Phentolamine Injection | |
404 Nicotinic Acid | 473 Phentolamine Mesylate | |
405 Nicoumalone | 474 Phenylephrine Injection | |
406 Nikethamide | 475 Phenylpropanolamine Hydrochloride | |
407 Nikethamide Infection | 476 Phosphoric Acid | |
408 Nitrazepam | 477 Phytomenadione Tablets | |
409 Nitrous Oxide | 478 Piperazine Adipate | |
410 Norethandrolone | 479 Piperazine Adipate Tablets | |
411 Norethandrolone Tablets | 480 Piperazine Citrate | |
412 Noscapine | 481 Piperazine Phosphate Tablets | |
413 Novobiocin Calcium | 482 Poldine Methylsulphate | |
414 Novobiocin Sodium | 483 Poldine Tablets | |
415 Novobiocin Tablets | 484 Poliomyelitis Vaccine (Inactivated) | |
416 Nux Vomica | 485 Poliomyelitis Vaccine (Oral) | |
417 Octaphoniurn Chloride | 486 Potassium Bromide | |
418 Octyl Gallate | 487 Potassium Chloride and Dextrose Injection | |
419 Oestradiol Benzoate | 488 Potassium Chloride and Sodium Chloride Injection | |
420 Oestradiol Benzoate Injection | 489 Potassium Chloride Tablets | |
421 Olive Oil | 490 Potassium Hydroxide | |
422 Opium | 491 Potassium Nitrate | |
423 Opium, Powdered | 492 Practolol | |
424 Orange Peel, Dried Bitter | 493 Practolol Injection | |
425 Orciprenaline Injection | 494 Practolol Tablets | |
426 Orphenadrine Citrate | 495 Prednisolone Pivalate | |
427 Orphenadrine Hydrochloride | 496 Prednisolone Pivalate Injection | |
428 Oxygen | 497 Prednisolone Sodium Phosphate | |
429 Oxyphenbutazone | Injection | |
430 Oxyphenbutazone Tablets | 498 Prednisone | |
431 Oxyphencyclimine Hydrochloride | 499 Pregelatinised Maize Starch | |
432 Oxyphencyclimine Tablets | 500 Prilocaine Hydrochloride | |
433 Oxytetracycline Tablets | 501 Primaquine Phosphate | |
434 Oxytocin Tablets | 502 Probenecid | |
435 Papaverine Hydrochloride | 503 Procainamide Tablets | |
436 Paramethadione | 504 Procaine and Adrenaline | |
437 Paramethadione Capsules | Injection | |
438 Penicillamine | 505 Prochlorperazine Maleate | |
439 Penicillamine Hydrochloride | 506 Prochlorperazine Mesylate | |
440 Pentaerythritol Tablets | 507 Procyclidine Hydrochloride | |
441 Pentagastrin | 508 Progesterone | |
442 Pentagastrin Injection | 509 Progesterone Injection | |
443 Pentamidine Injection | 510 Proguanil Hydrochloride | |
444 Pentamidine Isethionate | 511 Promazine Hydrochloride | |
445 Pentazocine | 512 Promazine Injection | |
446 Pentazocine Hydrochloride | 513 Promazine Tablets | |
447 Pentazocine Tablets | 514 Promethazine Theoclate | |
448 Pentolinium Tartrate | 515 Propanidid | |
449 Peppermint Oil | 516 Propantheline Bromide | |
450 Percutaneous Bacillus Calmette-Guérin Vaccine | 517 Propantheline Tablets | |
451 Perphenazine | 518 Propicillin Potassium | |
452 Perphenazine Tablets | 519 Propicillin Tablets | |
453 Pertussis Vaccine, Adsorbed | 520 Propranolol Hydrochloride | |
454 Pethidine Tablets | 521 Propyl Gallate | |
455 Phenacetin | 522 Propyliodone | |
456 Phenazocine Hydrobromide | 523 Propyliodone Injection | |
457 Phenazocine Injection | 524 Propyliodone Oily Injection | |
458 Phenazocine Tablets | 525 Propylthiouracil | |
459 Phenelzine Sulphate | 526 Pyrazinamide | |
460 Phenindamine Tartrate | 527 Pyridostigmine Bromide | |
461 Phenindione | 528 Pyrimethamine | |
462 Phenmetrazine Hydrochloride | 529 Pyroxylin | |
Schedule 1—
530 Quillaia | 594 Sulphomyxin Injection | |
531 Quinine Bisulphate | 595 Sulphomyxin Sodium | |
532 Quinine Dihydrochloride | 596 Sulthiame | |
533 Quinine Dihydrochloride Injection | 597 Suxamethonium Bromide | |
534 Quinine Hydrochloride | 598 Suxamethonium Bromide Injection | |
535 Quinine Sulphate | 599 Suxamethonium Chloride | |
536 Rabies Antiserum | 600 Suxamethonium Chloride Injection | |
537 Rubella Vaccine (Live Attenuated) | 601 Tartaric Acid | |
538 Saccharin | 602 Testosterone | |
539 Saccharin Sodium | 603 Testosterone Implants | |
540 Secbutobarbitone | 604 Testosterone Phenylpropionate | |
541
L-Selenomethionine ( | Injection | |
542 Senna Fruit | 605 Tetanus and Pertussis Vaccine | |
543 Senna Tablets | 606 Tetanus Antitoxin | |
544 Sesame Oil | 607 Tetanus Vaccine | |
545 Silver Nitrate, Toughened | 608 Tetrachloroethylene | |
546 Slow Lithium Carbonate Tablets | 609 Tetrachloroethylene Capsules | |
547 Slow Orphenadrine Citrate Tablets | 610 Tetracycline Injection | |
548 Smallpox Vaccine, Dried | 611 Tetracycline Tablets | |
549 Soda Lime | 612 Theobroma Oil | |
550 Sodium Acetrizoate Injection | 613 Thiambutosine | |
551 Sodium Aminosalicylate | 614 Thiamine Hydrochloride | |
552 Sodium Aurothiomalate | 615 Thiomersal | |
553 Sodium Bicarbonate Compound Tablets | 616 Thiopentone Sodium | |
554 Sodium Bromide | 617 Thiopentone Injection | |
555 Sodium Calciumedetate | 618 Thymoxamine Hydrochloride | |
556 Sodium Chloride Tablets | 619 Thymoxamine Tablets | |
557 Sodium
Chromate ( | 620 Thyroid | |
558 Sodium Citrate Tablets | 621 Thyroxine Sodium | |
559 Sodium Diatrizoate | 622 Tolazoline Hydrochloride | |
560 Sodium Diatrizoate Injection | 623 Tolazoline Tablets | |
561 Sodium Fluoride | 624 Tolbutamide | |
562 Sodium Fusidate Capsules | 625 Tolnaftate | |
563 Sodium Hydroxide | 626 Tranylcypromine Sulphate | |
564 Sodium
Iodide ( | 627 Triamterene Capsules | |
565 Sodium
Iodide ( | 628 Trichloroethylene | |
566 Sodium
Iodide ( | 629 Triclofos Tablets | |
567 Sodium
Iodohippurate ( | 630 Trimipramine Maleate | |
568 Sodium Iothalamate Injection | 631 Tropicamide | |
569 Sodium Lauryl Sulphate | 632 Troxidone | |
570 Sodium Methyl Hydroxybenzoate | 633 Tuberculin, Old | |
571 Sodium
Pertechnetate ( | 634 Tuberculin Purified Protein Derivative | |
572 Sodium
Phosphate ( | 635 Tubocurarine Chloride | |
573 Sodium Propyl Hydroxybenzoate | 636 Tubocurarine Injection | |
574 Sodium Stibogluconate | 637 Turpentine Oil | |
575 Sodium Stibogluconate Injection | 638 Typhoid and Tetanus Vaccine | |
576 Sorbitol | 639 Typhoid-paratyphoid A and B Vaccine | |
577 Sorbitol Injection | 640 Typhoid-paratyphoid A and B and Tetanus Vaccine | |
578 Spironolactone | 641 Typhoid-paratyphoid A and B and Cholera Vaccine | |
579 Stanolone | 642 Undecenoic Acid | |
580 Sterilizable Maize Starch | 643 Urea Injection | |
581 Stilboestrol | 644 Vasopressin Injection | |
582 Stramonium | 645 Vinyl Ether | |
583 Strong Potassium Chloride Solution | 646 Viomycin Sulphate | |
584 Sulphacetamide Eye Ointment | 647 Viomycin Sulphate | |
585 Sulphadimethoxine | Injection | |
586 Sulphadimethoxine Tablets | 648 Vitamin A Ester | |
587 Sulphadimidine injection | Concentrate | |
588 Sulphadimidine Sodium | 649 Warfarin Sodium | |
589 Sulphamethoxydiazine | 650 Xenon ( | |
590 Sulphamethoxypyridazine | 651 Xylose | |
591 Sulphapyridine | 652 Yellow Fever Vaccine | |
592 Sulphinpyrazone | 653 Zinc Undecenoate | |
593 Sulphobromophthalein Sodium | 654 Zinc Undecenoate Ointment | |
SCHEDULE 2 Sub-regulations 10 (3) and (4)
Allowable Compounds (if any) of Certain Drugs or Medicinal Preparations
Column 1 | Column 2 | Column 3 |
Item | Pharmaceutical benefit | Allowable compounds (if any) |
1 | Acepifylline................................................................... | — |
2 | Acetylcysteine.............................................................. | — |
3 | Acetylsulphafurazole.................................................. | — |
4 | Acrylic Resin................................................................ | — |
5 | Adrenaline Hydrochloride ......................................... | — |
6 | “ ALBUMAID XP ”.................................................... | — |
7 | Alginic Acid Compound............................................ | — |
8 | Aluminium Sodium Silicate....................................... | — |
9 | Amiloride Hydrochloride |
|
10 | Aminocaproic Acid...................................................... | — |
11 | “ AMINOFUSIN 5% ”................................................ | — |
12 | “ AMINOFUSIN 10% ”............................................. |
— | ||
13 | “ AMINOFUSIN A 5% WITH ALCOHOL............ | — |
14 | “ AMINOFUSIN STANDARD ”............................. | — |
15 | “ AMINOGRAN ”....................................................... | — |
16 | Amoxycillin Trihydrate.............................................. | Purified Water, B.P., with Amoxycillin Trihydrate |
17 | Amphotericin................................................................ | — |
18 | Ampicillin...................................................................... | — |
19 | Ampicillin Trihydrate................................................. | Purified Water, B.P., with Ampicillin Trihydrate |
20 | Antazoline Sulphate.................................................... | Naphazoline Nitrate with Antazoline Sulphate |
21 | Ascorbic Acid............................................................... |
|
Ferrous Sulphate mixture Prescribers’ List | ||
| ||
22 | Bacitracin...................................................................... |
|
23 | Bacitracin Zinc............................................................. | Neomycin Undecenoate with Bacitracin Zinc |
| ||
24 | “ BANISH ”.................................................................. | — |
25 | Beclomethasone Dipropionate | — |
26 | Benzathine Penicillin................................................... | Procaine Penicillin with Benzylpenicillin Potassium and Benzathine Penicillin |
27 | Benzylpenicillin Potassium....................................... |
|
28 | Benzylpenicillin Sodium............................................ | Procaine Penicillin with Benzylpenicillin Sodium |
29 | Betamethasone............................................................ | Betamethasone Acetate with Betamethasone |
30 | Betamethasone Acetate.............................................. | Betamethasone with Betamethasone Acetate |
31 | Betamethasone Sodium Phosphate | — |
32 | Betamethasone Phosphate......................................... | — |
33 | Bisacodyl....................................................................... |
|
34 | Brompheniramine Maleate........................................ | — |
35 | Bufexamac................................................................... | — |
36 | Calciferol....................................................................... | — |
37 | Calcium Chloride......................................................... |
|
38 | Calcium Lactate-Gluconate....................................... |
|
39 | Carbachol...................................................................... | Hypromellose 4500 with Carbachol |
40 | Carbidopa..................................................................... | Levodopa, B.P., with Carbidopa |
41 | Carbinoxamine Maleate............................................. | — |
42 | Cephradine.................................................................... | Purified Water, B.P., with Cephradine |
43 | Ceratonia, B.P.C. 1949............................................... | — |
44 | Chloramine, B.P.C....................................................... | — |
45 | Chloramphenicol......................................................... | Polymyxin B Sulphate with Chloramphenicol |
46 | Chloramphenicol Palmitate, B.P.C. | — |
Schedule 2—
Column 1 | Column 2 | Column 3 |
Item | Pharmaceutical benefit | Allowable compounds (if any) |
47 | Chloramphenicol Stearate.......................................... | — |
48 | Chlorhexidine Gluconate........................................... | — |
49 | Chlorpheniramine Maleate........................................ | — |
50 | Chlorpromazine Hydrochloride | — |
31 | Choline Theophyllinate.............................................. | Guaiphenesin, B.P.C., with Choline Theophyllinate |
52 | Clemastine Fumarate.................................................. | — |
53 | Clemizole Tannate...................................................... | — |
54 | Clindamycin Palmitate Hydrochloride |
|
55 | Cloxacillin Sodium...................................................... | Purified Water, B.P., with Cloxacillin Sodium |
56 | Colistin Sulphate......................................................... | Neomycin Sulphate with Colistin Sulphate |
57 | Cortisone Acetate........................................................ | — |
58 | Cyclizine Hydrochloride............................................ |
|
59 | Cyproheptadine Hydrochloride | — |
60 | Danthron....................................................................... | Dioctyl Sodium Sulphosuccinate, B.P.C., with Danthron |
61 | Demecarium Bromide................................................. | — |
62 | Dexamethasone........................................................... |
|
63 | Dexamethasone Metasulphobenzoate | Framycetin Sulphate with Gramicidin and Dexamethasone Metasulphobenzoate |
64 | Dexchlorpheniramine Maleate | — |
65 | Dextropropoxyphene Hydrochloride | Paracetamol with Dextropropoxyphene Hydrochloride |
66 | Diazepam...................................................................... | — |
67 | Dicyclomine Hydrochloride....................................... |
|
68 | Dienoestrol.................................................................... | — |
69 | “ DIGESTELACT ”.................................................... | — |
70 | Digoxin........................................................................... | — |
71 | Dihydrocodeine Tartrate............................................ | — |
72 | Dimethicone, B.P.C..................................................... | — |
73 | Dioctyl Sodium Sulphosuccinate, B.P.C. | Bisacodyl with Dioctyl Sodium Sulphosuccinate, B.P.C. |
Danthron with Dioctyl Sodium Sulphosuccinate, B.P.C. | ||
74 | Diphenhydramine Hydrochoride |
|
75 | Diphenoxylate Hydrochloride | Atropine Sulphate with Diphenoxylate Hydrochloride |
76 | Diphenylpyraline Hydrochloride | — |
77 | Diphtheria Vaccine Adsorbed | Diphtheria and Tetanus Vaccine, Adsorbed |
Diphtheria, Tetanus and Pertussis Vaccine, Adsorbed | ||
78 | Doxylamine Succinate................................................ | Dicyclomine Hydrochloride with Pyridoxine Hydrochloride and Doxylamine Succinate |
79 | Ecothiopate Iodide...................................................... | — |
80 | Ergometrine Maleate.................................................. | Oxytocin with Ergometrine Maleate |
81 | Ergotamine Tartrate.................................................... |
|
| ||
Caffeine with Ergotamine Tartrate | ||
| ||
82 | Erythromycin Estolate................................................ | — |
83 | Erythromycin Stearate................................................ | — |
84 | Ethinyloestradiol.......................................................... | Ethynodiol Diacetate with Ethinyloestradiol |
Lynoestrenol with, Ethinyloestradiol | ||
Norethisterone Acetate with Ethinyloestradiol | ||
Norgestrel with Ethinyloestradiol | ||
85 | Ethosuximide................................................................ | — |
86 | Ethynodiol Diacetate.................................................. | Ethinyloestradiol with Ethynodiol Diacetate |
Mestranol with Ethynodiol Diacetate |
Schedule 2—
Column 1 | Column 2 | Column 3 |
Item | Pharmaceutical benefit | Allowable compounds (if any) |
87 | Fenoterol Hydrobromide........................................... | — |
88 | Ferrous Aminoacetosulphate | — |
89 | Fluclorolone Acetonide............................................. | — |
90 | Fluocinolone Acetonide............................................. | — |
91 | Fluocortolone Hexanoate.......................................... | Fluocortolone Pivalate with Fluocortolone Hexanoate |
92 | Fluocortolone Pivalate............................................... | Fluocortolone Hexanoate with Fluocortolone Pivalate |
93 | Fluphenazine Hydrochloride | — |
94 | Flurandrenolone.......................................................... | — |
95 | Folic Acid..................................................................... | Ferrous Sulphate (Dried), B.P., with Folic Acid, B.P. |
96 | Framycetin Sulphate.................................................. |
|
| ||
97 | Fusidic Acid................................................................. | — |
98 | “ GALACTOMIN, FORMULA No. 17 ” | — |
99 | “ GALACTOMIN, FORMULA No. 19 ” | — |
100 | Glucose and Ketone Indicator | — |
101 | Glucose Indicator, Urine............................................ | — |
102 | “ GLUCOSE NUTRAMIGEN ” | — |
103 | Goats’ Milk.................................................................. | — |
104 | Goats’ Milk, Dehydrated.......................................... | — |
105 | Gramicidin.................................................................... |
|
Framycetin Sulphate with Dexamethasone Metasulphobenzoate and Gramicidin | ||
| ||
| ||
| ||
106 | Guaiphenesin, B.P.C................................................... | Theophylline with Guaiphenesin, B.P.C. |
107 | Hexamine Mandelate................................................ | — |
108 | Hydrochlorothiazide, B.P.......................................... | Amiloride Hydrochloride with Hydrochlorothiazide, B.P. |
Triamterene, B.P., with Hydrochlorothiazide, B.P. | ||
109 | Hydrocortisone............................................................ | Natamycin with Neomycin Sulphate and Hydrocortisone |
Neomycin Sulphate with Hydrocortisone | ||
. |
| |
110 | Hydrocortisone Acetate............................................. |
|
Neomycin Sulphate with Hydrocortisone Acetate | ||
| ||
111 | Hyoscine Hydrobromide........................................... |
|
Papaveretum with Hyoscine Hydrobromide, B.P. | ||
112 | Hyoscyamine Sulphate.............................................. |
|
113 | Idoxuridine................................................................... | — |
114 | “ ISOMIL ” | — |
115 | Isoprenaline Hydrochloride....................................... | — |
116 | “ KETOVITE ” Liquid | — |
117 | Lauryldimethylbenzyl Ammonium Chloride |
|
118 | Levallorphan Tartrate................................................ | Pethidine Hydrochloride with Levallorphan Tartrate |
119 | Levodopa, B.P............................................................. | Carbidopa with Levodopa, B.P. |
Schedule 2—
Column 1 | Column 2 | Column 3 |
Item | Pharmaceutical benefit | Allowable compounds (if any) |
120 | Lincomycin Hydrochloride........................................ | — |
121 | Locasol.......................................................................... | — |
122 | Lofenalac...................................................................... | — |
123 | Lynoestrenol................................................................. | Ethinylcestradiol with Lynoestrenol |
Mestranol with Lynoestrenol | ||
124 | Lypressin....................................................................... | — |
125 | Magnesium Aluminium Hydroxide | — |
126 | Magnesium Chloride................................................... |
|
127 | Magnesium Hydroxide, B.P.C. |
|
| ||
| ||
| ||
128 | Mebhydrolin Napadisylate, B.P.C. 1968 | — |
129 | Meclozine Hydrochloride........................................... |
|
130 | Medrysone.................................................................... | — |
131 | Mestranol...................................................................... | Ethynodiol Diacetate with Mestranol |
Lynoestrenol with Mestranol | ||
Norethisterone with Mestranol | ||
Norethynodrel with Mestranol | ||
132 | Methdilazine Hydrochloride...................................... | — |
133 | Methylprednisolone..................................................... | — |
134 | Morphine Tartrate....................................................... | Tacrine with Morphine Tartrate |
135 | Nalidixic Acid, B.P.C.................................................. | — |
136 | Naphazoline Hydrochloride....................................... | — |
137 | Naphazoline Nitrate..................................................... | Antazoline Sulphate with Naphazoline Nitrate |
138 | Natamycin.................................................................... | Neomycin Sulphate with Hydrocortisone and Natamycin |
139 | Neomycin Sulphate..................................................... |
|
Colistin Sulphate with Neomycin Sulphate | ||
| ||
Hydrocortisone Acetate with Neomycin Sulphate | ||
Hydrocortisone with Neomycin Sulphate | ||
Natamycin with Hydrocortisone and Neomycin Sulphate | ||
| ||
| ||
| ||
| ||
140 | Neomycin Undecenoate............................................. | Bacitracin Zinc with Neomycin Undecenoate |
141 | Neostigmine Methylsulphate | — |
142 | Nitrofurantoin............................................................... | — |
143 | Noradrenaline Acid Tartrate | — |
144 | Norethisterone | Mestranol with Norethisterone |
145 | Norethisterone Acetate............................................... | Ethinyloestradiol with Norethisterone Acetate |
146 | Norethynodrel............................................................... | Mestranol with Norethynodrel |
147 | Norgestrel....................................................................... | Ethinyloestradiol with Norgestrel |
148 | Nortriptyline Hydrochloride...................................... | — |
Schedule 2—
Column 1 | Column 2 | Column 3 |
Item | Pharmaceutical benefit | Allowable compounds (if any) |
149 | Nystatin......................................................................... |
|
Oxytetracycline Dihydrate with Nystatin | ||
Tetracycline, B.P.C., with a buffering agent and Nystatin | ||
Tetracycline Hydrochloride with Nystatin | ||
150 | Orciprenaline Sulphate............................................... | — |
151 | Oxytetracycline Dihydrate......................................... | Nystatin with Oxytetracycline Dihydrate |
152 | Oxytetracycline Hydrochloride, B.P. |
|
| ||
153 | Oxethazaine................................................................. | Aluminium Hydroxide Gel with Magnesium Hydroxide, B.P.C., and Oxethazaine |
154 | Oxytocin........................................................................ | Ergometrine Maleate with Oxytocin |
155 | Pancreatin..................................................................... | — |
156 | Pancreatin Enzyme, 4 times U.S.N.F.XIII strength | — |
157 | Papaveretum, B.P.C.................................................... | Hyoscine Hydrobromide with Papaveretum, B.P.C. |
158 | Pericyazine.................................................................... | — |
159 | Pertussis Vaccine......................................................... | Diphtheria, Tetanus and Pertussis Vaccine, Adsorbed |
160 | Pethidine Hydrochloride............................................ | Levallorphan Tartrate with Pethidine Hydrochloride |
161 | Phenethicillin Potassium............................................ | Purified Water, B.P., with Phenethicillin Potassium |
162 | Pheniramine Maleate.................................................. | — |
163 | Phenolphthalein........................................................... | Paraffin Liquid, B.P., with Phenolphthalein, B.P. |
164 |
| — |
165 | Phenytoin, B.P.C.......................................................... | — |
166 | Pholcodine.................................................................... | — |
167 | Pituitary (Posterior Lobe), Powdered, B.P.C. | — |
168 | “ PK AID I ” | — |
169 | “ PK AID II ” | — |
170 | Plasma Substitute (Polypeptide) | — |
171 | Polyisobutylene............................................................ | — |
172 | Polymyxin B Sulphate................................................ |
|
Chloramphenicol with Polymyxin B Sulphate | ||
| ||
| ||
| ||
| ||
| ||
| ||
173 | Polyvinylpyrrolidone and Vinyl Acetate Copolymer | — |
174 | Prednisolone................................................................. | — |
175 | Prednisolone Acetate.................................................. |
|
176 | Prednisolone Sodium Phosphate | — |
177 | “ PREGESTIMIL ” | — |
178 | Primidone...................................................................... | — |
Schedule 2—
Column 1 | Column 2 | Column 3 |
Item | Pharmaceutical benefit | Allowable compounds (if any) |
179 | Procaine Penicillin........................................................ |
|
Benzylpenicillin Sodium with Procaine Penicillin | ||
180 | Promethazine Hydrochloride | — |
181 | “ PROSOBEE ”............................................................ | — |
182 | Pseudoephedrine Hydrochloride | — |
183 | Pyrantel Embonate...................................................... | — |
184 | Pyridoxine Hydrochloride.......................................... |
|
185 | Salbutamol.................................................................... |
— | ||
186 | Salbutamol Sulphate................................................... | — |
187 | “ SOBEE ” | — |
188 | Sodium Acetate............................................................ |
|
189 | Sodium Acid Citrate.................................................... | — |
190 | Sodium Carboxymethylcellulose | Gelatin and Pectin with Sodium Carboxymethylcellulose |
191 | Sodium Gluconate....................................................... |
|
192 | Sodium Lactate............................................................ |
|
193 | “SOYALAC”................................................................. | — |
194 | Sterculia......................................................................... | — |
195 | Sulphafurazole............................................................. | — |
196 | Sulphamethizole........................................................... | — |
197 | Sulphamethoxazole..................................................... | Trimethoprim with Sulphamethoxazole |
198 | Sulphaphenazole, B.P.C.............................................. | — |
199 | Surgical Cement........................................................... | — |
200 | Surgical Cement Solvent............................................ | — |
201 | Tacrine........................................................................... | Morphine Sulphate with Tacrine |
Morphine Tartrate with Tacrine | ||
202 | Terbutaline Sulphate................................................... | — |
203 | “TERIC N8”.................................................................. |
|
204 | Testosterone Decanoate............................................. |
|
205 | Testosterone Isocaproate............................................ |
|
| ||
206 | Testosterone Phenylpropionate |
|
| ||
207 | Testosterone Propionate............................................. |
|
| ||
208 | Tetanus Vaccine, Adsorbed ....................................... | Diphtheria and Tetanus Vaccine, Adsorbed |
Diphtheria, Pertussis and Tetanus Vaccine, Adsorbed | ||
209 | Tetracyline, B.P.C........................................................ | Tetracycline, B.P.C., with a buffering agent |
Tetracycline, B.P.C., with a buffering agent and Nystatin | ||
210 | Tetracycline Hydrochloride........................................ | Tetracycline Hydrochloride with Nystatin |
211 | Thioridazine Hydrochloride | — |
212 | Thiotepa......................................................................... | — |
213 | Thonzonium Bromide................................................. |
|
Schedule 2—
Column 1 | Column 2 | Column 3 |
Item | Pharmaceutical benefit | Allowable compounds (if any) |
214 | Thonzylamine Hydrochloride |
|
215 | Triamcinolone Acetonide............................................ |
|
216 | Triamterene, B.P........................................................... | Hydrochlorothiazide, B.P. with Triamterene, B.P. |
217 | Triclofos Sodium.......................................................... | — |
218 | Trifluoperazine Hydrochloride | — |
219 | “TRIGLYDE”................................................................ | — |
220 | Trimeprazine Tartrate, B.P.C. | — |
221 | Trimethoprim................................................................ | Sulphamethoxazole with Trimethoprim |
222 | Triprolidine Hydrochloride......................................... | — |
223 | Urea................................................................................. | — |
224 | Viprynium Embonate.................................................. | — |
225 | “ZERODOR”................................................................. | — |
226 | “ZOFF”........................................................................... | — |
SCHEDULE 3 Sub-regulation 10 (2)
regulation 11 and
sub-regulation 35 (1)
Drugs and Medicinal Preparations Additional to the Drugs and Medicinal Preparations in the British Pharmacopoeia
1 Acepifylline | 61 Capsicum Ointment, B.P.C. |
2 Acetazolamide Sodium | 62 Carbidopa |
3 Acetohexamide | 63 Carbinoxamine Maleate |
4 Acetylcholine Chloride | 64 Cardamom Aromatic Tincture, B.P.C. |
5 Acetylcysteine | 65 Catechu Tincture, B.P.C. |
6 Acetylsulphafurazole | 66 Cephazolin Sodium |
7 Acidified Golden Syrup, A.P.F. 1955 | 67 Cephradine |
8 Acriflavine, B.P.C. 1963 | 68 Ceratonia, B.P.C. 1949 |
9 Acrylic Resin | 69 Charcoal, B.P.C. |
10 Adrenaline Hydrochloride | 70 Chloramine, B.P.C. |
11 “ ALBUMAID XP ” | 71 Chloramphenicol Palmitate, B.P.C. |
12 Alginic Acid Compound | 72 Chloramphenicol Sodium Succinate |
13 Aloxiprin | 73 Chlorhexidine Gluconate |
14 Aluminium Acetate Solution, B.P.C. | 74 Chlorinated Lime, B.P.C. |
| 75 Chlormethiazole |
16 Aluminium Sodium Silicate | 76 Chlormethiazole Edisylate |
17 Amantadine Hydrochloride 18 Amaranth, B.P.C. 1954 | 77 Cholestyramine |
19 Ambenonium Chloride | 78 Clemastine Fumarate |
20 Amiloride Hydrochloride | 79 Clemizole Hydrochloride |
21 Aminacrine Hydrochloride, B.P. 1968 | 80 Clemizole Tannate |
22 “ AMINOFUSIN 5% ” | 81 Clindamycin Hydrochloride |
23 “ AMINOFUSIN 10% ” | 82 Clindamycin Palmitate Hydrochloride |
24 “ AMINOFUSIN A 5% WITH ALCOHOL ” | 83 Clonazepam |
25 “ AMINOFUSIN STANDARD ” | 84 Clonidine Hydrochloride |
26 “ AMINOGRAN ” | 85 Clopamide |
27 Amitriptyline Embonate, B.P.C. | 86 Clorexolone |
28 Ammonia Aromatic Spirit, B.P.C. | 87 Coal Tar, B.P.C. |
29 Ammonia Solution, Strong, B.P.C. | 88 Coal Tar Solution, Strong, B.P.C. |
30 Ammonium Acetate Solution, Strong, | 89 Coconut Oil, B.P.C. |
B.P.C. | 90 Colaspase |
31 Ammonium Bicarbonate, B.P.C. | 91 Colophony Ointment, B.P.C. 1959 |
32 Angiotensin Amide | 92 Copper Sulphate, B.P.C. |
33 Antazoline Sulphate | 93 Creosote, B.P.C. 1959 |
34 Anthrax Antiserum | 94 Cyclothiazide |
35 Anthrax Vaccine | 95 Cycrimine Hydrochloride |
36 Anti-Haemophilic Factor of Animal | 96 Cytarabine Hydrochloride |
Origin | 97 Daunorubicin |
37 Atropine, B.P.C. | 98 Death Adder Antivenene |
38 Azatadine Maleate | 99 Debrisoquine |
39 Bacitracin, B.P. 1968 | 100 Demecarium Bromide |
40 Baclofen | 101 Dexamethasone Metasulphobenzoate |
41 “ BANISH ” | 102 Dexamethasone Sodium Phosphate |
42 Benzalkonium Chloride | 103 Dexchlorpheniramine Maleate |
43 Benzoin Compound Tincture, B.P.C. | 104 Dibenzepin Hydrochloride |
44 Betamethasone Acetate | 105 “ DIGESTELACT ” |
45 Betamethasone Phosphate | 106 Dihydroergotamine Mesylate |
46 Bethanechol Chloride | 107 Dimethicone, B.P.C. |
47 Biperiden Hydrochloride | 108 Dimethindene Maleate |
48 Bismuth Subgallate, B.P.C. | 109 Dioctyl Sodium Sulphosuccinate, B.P.C. |
49 Black Snake Antivenene | 110 Diphemanil Methylsulphate |
50 Bleomycin Sulphate | 111 Diphtheria and Tetanus Vaccine, Adsorbed, B.P., Diluted |
51 Brompheniramine Maleate | 112 Diphtheria Vaccine, Adsorbed, B.P., Diluted |
52 Brown Snake Antivenene | 113 Dipyridamole |
53 Buchu Concentrated Infusion, B.P.C. 1954 | 114 Doxylamine Succinate |
54 Bufexamac | 115 Droperidol |
55 Cade Oil, B.P.C. | 116 Ephedrine, B.P.C. |
56 Caffeine Citrate, B.P.C | 117 Epicillin |
. 1959 | 118 Epicillin Sodium |
57 Calcitonin (Salmon Synthetic) | 119 Erythromycin Ethylsuccinate |
58 Calcium Folinate | 120 Erythromycin Gluceptate |
59 Calcium Glubionate | 121 Erythromycin Lactobionate |
60 Calcium Lactate-Gluconate | 122 Ethanolamine Oleate |
123 Ethoxzolamide |
Schedule 3—
124 Ethylnoradrenaline Hydrochloride | 181 Lauryldimethylbenzyl Ammonium Chloride |
125 Fenoterol Hydrobromide | 182 Lavender Oil, Spike, B.P.C. 1968 |
126 Ferrous Aminoacetosulphate | 183 Lead Subacetate Strong Solution, B.P.C. |
127 Ferrous Phosphate Compound, Syrup, B.P.C. 1968 | 184 Lemon Oil Terpeneless, B.P.C. |
128 Fluclorolone Acetonide | 185 Lobelia Ethereal Tincture, B.P.C. |
129 Flucytosine | 186 Locasol |
130 Flumethasone Pivalate | 187 Lofenalac |
131 Fluorometholone | 188 Lypressin |
132 Fluorouracil Sodium | 189 Magenta, B.P.C. |
133 Flurandrenolone | 190 Magnesium-Aluminium Hydroxide |
134 Fusidic Acid | 191 Magnesium Chloride |
135 “ GALACTOMIN, FORMULA No. 17 ” | 192 Magnesium Hydroxide, B.P.C. |
136 “ GALACTOMIN, FORMULA No. 19 ” | 193 Maphenide Acetate |
137 Gelsemium Tincture, B.P.C. | 194 Mebhydrolin Napadisylate, B.P.C. 1968 |
138 Ginger Syrup, B.P.C. | 195 Mecamylamine Hydrochloride, B.P. 1968 |
139 Glucagon Hydrochloride | 196 Medroxyprogesterone Acetate |
140 Glucose and Ketone Indicator | 197 Medrysone |
141 Glucose Indicator—Urine | 198 Mefruside |
142 “ GLUCOSE NUTRAMIGEN ” | 199 Mercuric Chloride, B.P.C. |
143 Glycerophosphate Compound Syrup, A.P.F. 1964 | 200 Methdilazine Hydrochloride |
144 Glymidine | 201 Methenolone Acetate |
145 Goats’ Milk, Dehydrated | 202 Methsuximide |
146 Goats’ Milk, Whole (Sterilised) | 203 Methyclothiazide |
147 Gramicidin | 204 Methylphenobarbitone B.P.C. 1963 |
148 Guaiphenesin, B.P.C. | 205 Methylprednisolone Acetate |
149 Haemodialysis Solutions. B.P.C. | 206 Methylprednisolone Sodium Succinate |
150 Hamamelis Liquid Extract, B.P.C. | 207 Methysergide Maleate |
151 Heparin Calcium | 208 Metoclopramide Hydrochloride |
152 Hexamine Hippurate | 209 Minocycline Hydrochloride |
153 Hexamine Mandelate | 210 Mithramycin |
154 Hydrallazine Hydrochloride | 211 Morphine Tartrate |
155 Hydrargaphen | 212 Myrrh Tincture, B.P.C. |
156 Hydromorphone Hydrochloride | 213 Nalidixic Acid, B.P.C. |
157 Hydroxyurea | 214 Naphazoline Hydrochloride |
158 Hyoscine Butylbromide | 215 Natamycin |
159 Hyoscyamine Sulphate | 216 Neomycin Undecenoate |
160 Hyoscyamus Liquid Extract, B.P.C. | 217 Norgestrel |
161 Hypromellose 4500, B.P.C. | 218 Oestradiol Valerate |
162 Ichthammol, B.P.C. | 219 Oestrone, B.P.C. 1954 |
163 Influenza Vaccine—Sub Unit Type | 220 Orange Syrup, B.P.C. |
(Deoxycholate Treated) | 221 Orange Tincture, B.P.C. |
164 Injection of Potassium Chloride with Sodium Lactate and Anhydrous Dextrose | 222 Oxazepam |
165 Insect Allergen Extract—Bull Ant | 223 Oxethazaine |
165 Insect Allergen Extract—Honey Bee | 224 Oxycodone Pectinate |
167 Insect Allergen Extract—Jumper Ant | 225 Oxymel, B.P.C. |
168 Insect Allergen Extract—Mosquito | 226 Oxymetholone |
169 Insect Allergen Extract—Paper Wasp | 227 Oxyphenonium Bromide |
170 Insulin Injection Neutral, Specially | 228 Oxytocin |
Purified—Monocomponent | 229 Pancreatin Enzyme, U.S.N.F. XIII |
171 Insulin Injection, specially purified | 230 Pancrelipase |
172 Insulin Isophane Injection, specially purified | 231 Papaveretum, B.P.C. |
173 Insulin Zinc Suspension (Amorphous), Specially Purified Injection— | 232 Paraffin Liquid Light, B.P.C. 1963 |
Monocomponent | 233 Paramethasone Acetate |
174 Insulin Zinc Suspension, Specially Purified Injection—Monocomponent | 234 Pectin |
175 Intraperitoneal Dialysis Solutions, B.P.C. | 235 Pempidine Tartrate, B.P. 1968 |
176 Iron Polymaltose Complex | 236 Penicillinase |
177 “ ISOMIL ” | 237 Pericyazine |
178 “ KETOVITE ” Liquid | 238 Pheniramine Aminosalicylate |
179 “ KETOVITE ” Tablets | 239 Pheniramine Maleate |
180 Lactulose | 240 Phenoxymethylpenicillin, Benzathine |
241 Phenoxymethylpenicillin, Hydrabamine | |
242 Phensuximide, B.P.C. | |
243 Phenytoin, B.P.C. | |
244 Phthalylsulphacetamide | |
245 Physostigmine, B.P.C. | |
246 Pilocarpine Hydrochloride, B.P.C. | |
247 Pindolol |
Schedule 3—
248 Pituitary Hormone, Follicle-stimulating, Human | 300 Sodium Lactate |
249 Pituitary Hormone, Growth, Human | 301 Sodium Nitroprusside |
250 Pituitary (Posterior Lobe) Powdered, B.P.C. | 302 Sorbide Nitrate |
251 Pizotifen Malate | 303 “ SOYALAC ” |
252 “ PK AID I ” | 304 Spectinomycin Dihydrochloride Pentahydrate |
253 “ PK AID II ” | 305 Squill Oxymel, B.P.C. |
254 Plasma Substitute (Polypeptide) | 306 Squill Syrup. B.P.C. |
255 Polyisobutylene | 307 Squill Tincture. B.P.C. |
256 Polyoestradiol Phosphate | 308 Staphylococcus Toxoid, B.P. 1968 |
257 Polyvinyl Alcohol | 309 Stearic Acid, B.P.C. |
258 Polyvinylpyrrolidone and Vinyl Acetate Copolymer | 310 Sterculia. B.P.C. |
259 Potassium Chlorate, B.P.C. | 311 Stilboestrol Diphosphate |
260 Potassium Effervescent Tablets | 312 Stone Fish Antivenene |
261 Pralidoxime Iodide | 313 Stramonium Liquid Extract, B.P. 1968 |
262 Prazosin Hydrochloride | 314 Sulphaphemizole, B.P.C. 1968 |
263 Prednisolone Acetate | 315 Sulphasalazine |
264 Prednisolone Steaglate | 316 Sulphasymazine |
265 Prednisolone Tertiarybutylacetate | 317 Sulphurated Potash, B.P.C. |
266 “ PREGESTIMIL ” | 318 Sulphur Sublimed, B.P.C. |
267 Procarbazine Hydrochloride | 319 Surgical Cement |
268 Prochlorperazine | 320 Surgical Cement Solvent |
269 Prochlorperazine Edisylate | 321 Tacrine |
270 Proflavine Hemisulphate, B.P.C. | 322 Taipan Antivenene |
271 Proscillaridin | 323 Tartrazine, B.P.C. 1954 |
272 “ PROSOBEE ” | 324 Terbutaline Sulphate |
273 Pumilio Pine Oil, B.P.C. | 325 “ TERIC N8 ” |
274 Pyrantel Embonate | 326 Testosterone Decanoate |
275 Quillaia Tincture, B.P.C. | 327 Testosterone Enanthate |
276 Quinethazone | 328 Testosterone Isocaproate |
277 Quinidine Bisulphate | 329 Tetracycline, B.P.C. |
278 Rabies Vaccine (Duck Type) | 330 Thiabendazole, B.P.C. |
279 Rabies Vaccine (Serum Type) | 331 Thiethylperazine Malate |
280 Raspberry Syrup, B.P.C. | 332 Thiethylperazine Maleate |
281 Rauwolfia Alkaloids | 333 Thioguanine |
282 Rauwolfia Serpentina, B.P.C. | 334 Thiopropazate Hydrochloride, B.P.C. |
283 Red Back Spider Antivenene | 335 Thonzonium Bromide |
284 Rolitetracycline | 336 Thonzylamine Hydrochloride |
285 Rosemary Oil, B.P.C. | 337 Tiger Snake Antivenene |
286 Saccharin Tablets, B.P.C. | 338 Tinidazole |
287 Salicylamide | 339 Titanium Dioxide, B.P.C. |
288 Sea Wasp Antivenene | 340 Tobramycin Sulphate |
289 Secbutobarbitone Sodium | 341 Tolazamide |
290 Senega, Concentrated Infusion. B.P.C. | 342 Tolu Syrup, B.P.C. |
291 Siberian Fir Oil, B.P.C. 1949 | 343 Triethanolamine, B.P.C. |
292 Silver Protein, B.P.C. 1968 | 344 “ TRIGLYDE ” |
293 Silver Protein Mild, B.P.C. 1968 | 345 Trimeprazine Tartrate, B.P.C. |
294 Snake Bite Antivenene—Polyvalent | 346 Trimetaphan Camsylate B.P. 1968 |
295 “ SOBEE ” | 347 Trioxysalen |
296 Sodium Carboxymethylcellulose | 348 Vasopressin Tannate |
297 Sodium Citro-Tartrate | 349 Verapamil Hydrochloride |
298 Sodium Gluconate | 350 “ ZERODOR ” |
299 Sodium Hypochlorite Solution. Strong, B.P.C. | 351 “ ZOFF ” |
SCHEDULE 4 Regulation 12 and sub-regulation 35 (1)
Additives
1 Acetone, B.P.C. | 18 Ether, Solvent, B.P. |
2 Alcohol (95%), B.P. | 19 Eucalyptus Oil, B.P. |
3 Arachis Oil, B.P. | 20 Honey, Purified, B.P.C. |
4 Camphor, B.P. | 21 Hypromellose 4500, B.P.C. |
5 Caramel Solution, A.P.F. | 22 Industrial Methylated Spirit, |
6 Castor Oil, B.P. | B.P. |
7 Chlorhexidine Acetate, B.P.C. | 23 Linseed Oil |
8 Chlorhexidine Gluconate Solution, B.P. | 24 Maize Oil, B.P. |
9 Chloroform, B.P. | 25 Methylcellulose 20, B.P.C. |
10 Cincole, B.P.C. | 26 Methylcellulose 4500, B.P.C. |
11 Citronella Oil, B.P.C. | 27 Olive Oil, B.P. |
12 Concentrated Anise Water, B.P.C. | 28 Peppermint Oil, B.P. |
13 Concentrated Cinnamon Water, B.P.C. | 29 Saccharin Sodium, B.P. |
14 Concentrated Peppermint Water, B.P. | 30 Sodium Thiosulphate, B.P.C. |
15 Dextrose, B.P. | 31 Syrup of Pholcodine Citrate, B.P.C. 1959 |
16 Dilute Alcohols, B.P. | 32 Turpentine Oil, B.P. |
17 Ether, Anaesthetic, B.P. | 33 Xylene, B.P.C. 194 |
SCHEDULE 5 Sub-regulations 14 (1), (2) and
(5), 19 (1), 21 (1) and 22 (2)
Pharmaceutical Benefits the Prescribing of which is Subject to Conditions and Restrictions
Column 1 | Column 2 | Column 3 |
Item | Pharmaceutical benefit | Purpose for which, and the conditions subject to which, the pharmaceutical benefit may be prescribed (including any restrictions as to the persons for whose treatment it may be prescribed) for supply under Part VII of the Act |
1 | Acetylcysteine............................................ | Bronchiectasis |
Cystic fibrosis (mucoviscidosis) | ||
2 | Acrylic Resin | Ileostomy or colostomy conditions |
3 | “ ALBUMAID XP ”................................. | Phenylketonuria |
4 | Alginic Acid Compound......................... |
|
5 | Alprenolol Injection, B.P.......................... | Dissecting aneurysm (aortic) |
Idiopathic hypertrophic subaortic stenosis | ||
Right ventricular outflow tract obstruction | ||
Serious arrhythmias | ||
| ||
Thyrotoxicosis | ||
6 | Alprenolol Tablets, B.P............................ | Dissecting aneurysm (aortic) |
Hypertension | ||
Idiopathic hypertrophic subaortic stenosis | ||
Right ventricular outflow tract obstruction | ||
Serious arrhythmias | ||
| ||
Thyrotoxicosis | ||
7 | Amantadine Hydrochloride..................... |
|
8 | (1) Aminocaproic Acid, B.P. |
|
(2) Aminocaproic Acid Injection, B.P. | ||
9 | “ AMINOGRAN ” | Phenylketonuria |
10 | Ascorbic Acid Tablets, B.P. | Any disease or condition in a pensioner |
11 | Azathioprine Tablets, B.P........................ |
|
With the written authority of the Director-General— | ||
Anaemia, autoimmune haemolytic | ||
| ||
| ||
Crohn’s disease | ||
Dermatomyositis | ||
Granulomatosis, Wegener’s | ||
Hepatitis, active, chronic | ||
Lupus erythematosus, systemic | ||
Nephritis | ||
Nephrotic syndrome | ||
Organ transplant | ||
Pemphigus vulgaris | ||
Polyarteritis nodosa | ||
Pyoderma gangrenosum | ||
Scleroderma | ||
Thrombocytopenic purpura | ||
Ulcerative colitis | ||
12 | Baclofen...................................................... |
|
13 | “ BANISH ”................................................ | Ileostomy or colostomy conditions |
Schedule 5—
Column 1 | Column 2 | Column 3 |
Item | Pharmaceutical benefit | Purpose for which, and the conditions subject to which, the pharmaceutical benefit may be prescribed (including any restrictions as to the persons for whose treatment it may be prescribed) for supply under Part VII. of the Act |
14 | Beclomethasone Dipropionate metered aerosol spray | Chronic intractable asthma requiring maintenance corticosteroids |
15 | Benzoin Compound Tincture, B.P.C., Aerosol Spray | Ileostomy or colostomy conditions |
16 |
| Alopecia areata |
Granulomata, dermal |
Keloid | ||
Lichen planus hypertrophic | ||
Lichen simplex chronicus | ||
Local intra-articular or peri-articular infiltration | ||
Lupus erythematosus, chronic discoid | ||
Necrobiosis lipoidica | ||
Uveitis | ||
17 | Bisacodyl Suppositories, B.P. | Any disease or condition in a paraplegic or quadriplegic patient |
| ||
18 | Bleomycin Sulphate.................................. | Choriocarcinoma of the testis |
Embryonal cell carcinoma of the testis | ||
Lymphoma | ||
Squamous cell carcinoma | ||
19 | (1) Calciferol, B.P...................................... | With the written authority of the Director-General— |
(2) Calciferol Tablets, Strong, B.P. | Hypocalcaemia | |
Hypoparathyroidism | ||
| ||
Vitamin D-resistant rickets | ||
20 | Calcium Carbonate, B.P., with Calcium Lactate-Gluconate | With the written authority of the Director-General— |
Hypocalcaemia | ||
Osteoporosis | ||
21 | Calcium Carbonate, B.P., with Citric Acid, B.P., Compound Effervescent Tablets | With the written authority of the Director-General— |
Hypocalcaemia | ||
Osteoporosis | ||
22 | Calcium Folinate....................................... | Antidote to folic acid antagonists |
23 | Carbenicillin Sodium................................ |
|
With the written authority of the Director-General— | ||
| ||
Septicaemia, suspected or proven | ||
24 | Carbenoxolone Tablets, B.P. |
|
25 | (1) Cephalexin Capsules, B.P. |
|
(2) Cephalexin Tablets, B.P..................... | ||
(3) Cephalexin. B.P., with Purified Water, B.P. |
| |
26 | Cephaloridine............................................. |
|
27 | Cephalothin Sodium................................. |
|
28 | Cephazolin Sodium................................... |
|
Schedule 5—
Column 1 | Column 2 | Column 3 |
Item | Pharmaceutical benefit | Purpose for which, and the conditions subject to which, the pharmaceutical benefit may be prescribed (including any restrictions as to the persons for whose treatment it may be prescribed) for supply under Part VII. of the Act |
29 | (1) Cephradine Capsules.......................... |
|
(2) Cephradine with Purified Water, B.P. | ||
30 | Cephradine for Injection |
|
31 | Charcoal Tablets........................................ | Ileostomy or colostomy conditions |
32 | Chlorambucil Tablets, B.P....................... |
|
With the written authority of the Director-General— | ||
Anaemia, autoimmune, haemolytic | ||
Arthritis, rheumatoid with vasculitis or visceral complications | ||
| ||
Crohn’s disease | ||
Dermatomyositis | ||
Granulomatosis, Wegener’s | ||
Hepatitis, active chronic | ||
Lupus erythematosus, systemic | ||
Malignant disease including leukaemia | ||
Nephritis | ||
Nephrotic syndrome | ||
Polyarteritis nodosa | ||
Scleroderma | ||
Thrombocytopenic purpura | ||
Ulcerative colitis | ||
33 | Chloramine Deodorant Tablets and Powder | Ileostomy or colostomy conditions |
34 | (1) Chloramphenicol Capsules, B.P. | Bacterial meningitis |
Intraocular infections | ||
| Rickettsioses | |
Typhoid | ||
(3) Chloramphenicol Palmitate Oral Suspension |
| |
35 | (1) Chlormethiazole .. |
|
(2) Chlormethiazole | Status epilepticus | |
Edisylate | ||
36 | Chlorotrianisene Tablets........................... | Carcinoma of the prostate |
37 | (1) Chlorpromazine Hydrochloride, B.P. |
|
(2) Chlorpromazine Injection, B.P. | Chorea | |
Hyperactive states of organic or toxic delirium | ||
(3) Chlorpromazine Tablets, B.P. | Major psychoses including— | |
Major organic psychoses including arteriopathic dementia | ||
Manic-depressive psychosis | ||
Paranoid states | ||
Schizophrenia | ||
Senile dementia | ||
Malignant neoplasia (late stage) | ||
Radiation sickness | ||
|
Schedule 5—
Column 1 | Column 2 | Column 3 |
Item | Pharmaceutical benefit | Purpose for which, and the conditions subject to which, the pharmaceutical benefit may be prescribed (including any restrictions as to the persons for whose treatment it may be prescribed) for supply under Part VII of the Act |
38 | Cholestyramine........................................... | With the written authority of the Director-General— |
| ||
| ||
| ||
39 | (1) Clindamycin Hydrochloride | Gram-positive coccal infections where the infection cannot be safely and affectively treated with penicillin or a derivative of penicillin |
(2) Clindamycin Palmitate Hydrochloride | ||
40 | Clofibrate Capsules, B.P............................ | With the written authority of the Director-General— |
Diabetic retinopathy (exudative) | ||
Initial treatment with clofibrate of hyperlipidaemia not responding to dietary therapy | ||
A second or subsequent course of treatment of hyperlipidaemia where significant lowering of serum triglyceride or serum cholesterol subsequent to initial treatment with clofibrate has been established by laboratory report | ||
41 | Clonazepam................................................ | Epilepsy |
42 | (1) Cloxacillin Capsules, B.P. | Any disease or condition in a patient receiving treatment in or at an approved hospital |
| ||
With the written authority of the Director-General— | ||
| ||
Osteomyelitis | ||
43 |
| Any disease or condition in a pensioner |
| ||
44 |
| Malignant neoplasia |
45 |
| Pyocyaneus infection, other gram-negative infections where no other drug is effective |
46 | Cyanocobalamin Injection, B.P. | Neuroblastoma |
Pernicious anaemia and other proven Vitamin B12 deficiencies | ||
Post-gastrectomy treatment | ||
Sub-acute combined degeneration of the cord |
Schedule 5—
Column 1 | Column 2 | Column 3 |
Item | Pharmaceutical benefit | Purpose for which, and the conditions subject to which, the pharmaceutical benefit may be prescribed (including any restrictions as to the persons for whose treatment it may be prescribed) for supply under Part VII of the Act |
47 | (1) Cyclophosphamide B.P. |
|
(2) Cyclophosphamide Tablets, B.P. | ||
With the written authority of the Director-General— | ||
Anaemia, autoimmune, haemolytic | ||
Arthritis, rheumatoid with vasculitis or visceral complications | ||
| ||
Crohn’s disease | ||
Dermatomyositis | ||
Granulomatosis, Wegener’s | ||
Hepatitis, active, chronic | ||
Lupus erythematosus, systemic | ||
Malignant disease, including leukaemia | ||
Nephritis | ||
Nephrotic syndrome | ||
Pemphigus vulgaris | ||
Polyarteritis nodosa | ||
Scleroderma | ||
Thrombocytopenic purpura | ||
Ulcerative colitis | ||
48 |
| Any disease or condition in a paraplegic or quadriplegie patient |
Ileostomy or colostomy conditions | ||
49 |
| For use in a hospital |
50 | Dexamphetamine Tablets, B.P. | With the written authority of the Director-General— |
| ||
Narcolepsy | ||
51 | (1) Dextromoramide Tablets, B.P. | Treatment in malignant neoplasia |
(2) Dextromoramide Tartrate, B.P. | ||
52 |
| Vomiting in pregnancy |
53 | “DIGESTELACT”..................................... |
|
54 | Dihydrotachysterol.................................... | With the written authority of the Director-General— |
Hypoparathyroidism | ||
| ||
Vitamin D-resistant rickets | ||
55 | Dimethicone Aerosol Spray.................... | Ileostomy or colostomy conditions |
56 | Dimethicone Creams................................ | Any disease or condition in a paraplegic or quadriplegic patient |
Use with surgical appliances | ||
57 | (1) Dioctyl Sodium Sulphosuccinate | Any disease or condition in a paraplegic or quadriplegic patient |
(2) Dioctyl Sodium Sulphosuccinate with Bisacodyl |
| |
(3) Dioctyl Sodium Sulphosuccinate with Danthron |
Schedule 5—
Column 1 | Column 2 | Column 3 |
Item | Pharmaceutical benefit | Purpose for which, and the conditions subject to which, the pharmaceutical benefit may be prescribed (including any restrictions as to the persons for whoso treatment it may be prescribed) for supply under Part VII of the Act |
58 | Diphemanil Methylsulphate | Amputees |
Any disease or condition in a paraplegic or quadriplegic patient | ||
59 | Dipyridamole.............................................. | Supplementing anticoagulants in— |
Biopsy proven glomerulonephritis | ||
Microangiopathic renal disease | ||
Renal allograft | ||
Patients with cardiac prosthesis | ||
60 | Droperidol.................................................... |
|
61 | Ethyloestrenol Tablets, B.P. | With the written authority of the Director-General— |
Osteoporosis | ||
Patients on long-term treatment with corticosteroids | ||
62 | Flucytosine |
|
63 | Fluoxymesterone Tablets, B.P. | Carcinoma of the breast |
Hypogonadism | ||
With the written authority of the Director-General— | ||
Aplastic anaemias, proven | ||
Osteoporosis | ||
64 | (1) Fluphenazine Decanoate Injection, B.P. |
|
(2) Fluphenazine Enanthate Injection, B.P. | Chorea | |
Hyperactive states of organic or toxic delirium | ||
(3) Fluphenazine Hydrochloride, B.P. | Major psychoses including— | |
Major organic psychoses including arteriopathic dementia | ||
(4) Fluphenazine Tablets, B.P. | ||
Manic-depressive psychosis | ||
Paranoid states | ||
Schizophrenia | ||
Senile dementia | ||
Malignant neoplasia (late stage) | ||
Radiation sickness | ||
65 | (1) Folic Acid, B.P..................................... | Cystic fibrosis |
(2) Folic Acid Tablets, B.P., 5 mg | Haemolytic anaemia, chronic | |
Proven folic acid deficiency | ||
Sprue or the sprue-like syndrome | ||
66 | Frusemide Tablets, B.P., 500 mg | Renal failure |
67 | Fusidic Acid................................................ |
|
| ||
68 | “ GALACTOMIN FORMULA No. 17 ” | With the written authority of the Director-General— |
Galactosaemia | ||
| ||
69 | “ GALACTOMIN FORMULA No. 19 ” |
|
70 | Gentamicin Injection, B.P........................ |
|
With the written authority of the Director-General— | ||
| ||
Septicaemia including suspected septicaemia |
Schedule 5—
Column 1 | Column 2 | Column 3 |
Item | Pharmaceutical benefit | Purpose for which, and the conditions subject to which, the pharmaceutical benefit may be prescribed (including any restrictions as to the persons for whose treatment it may be prescribed) for supply under Part VII of the Act |
71 | “ GLUCOSE NUTRAMIGEN ” | With the written authority of the Director-General— |
| ||
Cystic fibrosis (mucoviscidosis) | ||
Galactosaemia | ||
Lactose intolerance | ||
72 | Glycerol Suppositories, B.P. | Any disease or condition in a paraplegic or quadriplegic patient |
| ||
73 | Goats’ Milk, Dehydrated.......................... |
|
74 | Goats’ Milk, Whole (Sterilized) |
|
75 | Griseofulvin Tablets, B.P.......................... | With the written authority of the Director-General— |
| ||
Kerion | ||
76 | (1) Haloperidol........................................... |
|
(2) Haloperidol Tablets, B.P. | ||
Chorea | ||
Hyperactive states of organic or toxic delirium | ||
Malignant neoplasia (late stage) | ||
Radiation sickness | ||
Major psychoses including— | ||
Major organic psychoses including arteriopathic dementia | ||
Manic-depressive psychoses | ||
Paranoid states | ||
Schizophrenia | ||
Senile dementia | ||
77 |
| Cardiac failure |
| ||
78 | Hydrocortisone Acetate Injection, B.P. | Alopecia areata |
Granulomata, dermal | ||
Keloid | ||
Lichen planus hypertrophic | ||
Lichen simplex chronicus | ||
Local intra-articular or peri-articular infiltration | ||
Lupus erythematosus, chronic discoid | ||
79 | Hydrocortisone Sodium Succinate Injection, 500 mg |
|
80 | Hydroxocobalamin Injection, B.P. | Neuroblastoma |
Pernicious anaemia and other proven Vitamin B12 deficiencies | ||
Post-gastrectomy treatment | ||
Sub-acute combined degeneration of the cord | ||
81 | Ibuprofen Tablets....................................... | Osteoarthritis where salicylates are contra-indicated or ineffective |
|
Schedule 5—
Column 1 | Column 2 | Column 3 |
Item | Pharmaceutical benefit | Purpose for which, and the conditions subject to which, the pharmaceutical benefit may be prescribed (including any restrictions as to the persons for whose treatment it may be prescribed) for supply under Part VII of the Act |
82 | (1) Idoxuridine Eye Drops...................... | Infections caused by Herpes Simplex Virus or by Vaccinia Virus |
(2) Idoxuridine Eye Ointment | ||
83 | Influenza Vaccine.................................... | For prophylaxis of— |
pensioners | ||
| ||
84 | “ ISOMIL ”................................................ | With the written authority of the Director-General— |
| ||
| ||
| ||
| ||
85 | Kanamycin Injection, B.P....................... |
|
Septicaemia, including suspected septicaemia | ||
86 | (1) “ KETOVITE ” Liquid...................... | With the written authority of the Director-General— |
(2) “ KETOVITE ” Tablets.................... | Galactosaemia | |
Persistent monosaccharide intolerance | ||
Phenylketonuria | ||
Tyrosinosis (hereditary) | ||
87 | Lactulose.................................................... | Hepatic coma or pre-coma (chronic portosystemic encephalopathy) |
88 | Levodopa, B.P., with Carbidopa |
|
89 | (1) Levodopa Capsules, B.P. | Treatment of Parkinson’s Disease |
(2) Levodopa Tablets, B.P. | ||
90 | (1) Lignocaine Hydrochloride, B.P., Injection | Cardiac arrhythmias |
(2) Lignocaine Hydrochloride Injection, B.P. |
91 | Lincomycin Hydrochloride, B.P. | Osteomyelitis |
92 | Lincomycin Injection, B.P...................... | Gram-negative anaerobic infections |
| ||
93 | Lithium Carbonate Tablets, B.P. | Manic depression |
94 | Locasol....................................................... | With the written authority of the Director-General— |
| ||
Osteopetrosis | ||
95 | Lofenalac................................................... | Phenylketonuria |
96 | Maphenide Acetate.................................. | Treatment, in a hospital, of burns |
97 |
| Malignant neoplasia |
Precocious puberty | ||
| ||
98 | Medroxyprogesterone Acetate Tablets, 2.5 mg | Precocious puberty |
Turner’s syndrome | ||
99 | Medroxyprogesterone Acetate Tablets, 10 mg | Malignant neoplasia |
Precocious puberty | ||
Turner’s syndrome | ||
100 | Medroxyprogesterone Acetate Tablets, 100 mg | Malignant neoplasia |
Schedule 5—
Column 1 | Column 2 | Column 3 |
Item | Pharmaceutical benefit | Purpose for which, and the conditions subject to which, the pharmaceutical benefit may be prescribed (including any restrictions as to the persons for whose treatment it may be prescribed) for supply under Part VII of the Act |
101 | (1) Metformin Hydrochloride, B.P. |
|
(2) Metformin Tablets, B.P.................... | ||
102 | (1) Methadone Injection, B.P. |
|
(2) Methadone Tablets, B.P................... | ||
103 | (1) Methandienone Tablets, B.P. | With the written authority of the Director-General— |
Osteoporosis | ||
(2) Methenolone Acetate....................... | Patients on long-term treatment with corticosteroids | |
104 | Methicillin Sodium, B.P., for injection | Proven or suspected staphylococcal septicaemia |
105 | (1) Methotrexate Injection.................... |
|
(2) Methotrexate Tablets....................... | ||
With the written authority of the Director-General— | ||
| ||
Malignant neoplasia | ||
Pemphigus vulgaris | ||
Severe intractable or extensive psoriasis | ||
106 | Methylphenobarbitone........................... | Epilepsy |
107 | Methylprednisolone Acetate Injection | For local intra-articular or peri-articular infiltration |
Intrathecal use | ||
108 | Methylprednisolone Acetate Retention Enema | Proctitis |
Ulcerative colitis | ||
109 | Methyltestosterone Tablets, B.P., 5 mg | Hypogonadism in patients who have not attained the age of 16 years |
110 | (1) Methyltestosterone, B.P................... | Carcinoma of the breast |
(2) Methylestosterone Tablets, B.P., 25 mg or 50 mg | Hypogonadism | |
Klinefelter’s syndrome (seminiferous tubule dysgenesis) | ||
111 | Methysergide Malcate | Carcinoid syndrome |
Prevention of disabling migraine when other treatment has failed | ||
112 | Mithramycin............................................. | For use in a hospital for— |
Inoperable testicular neoplasm | ||
| ||
113 | Morphine Sulphate, B.P., with Tacrine, Tablets | Severe intractable pain |
114 | Nalidixic Acid.......................................... |
|
115 | Nandrolone Decanoate Injection, B.P. | Carcinoma of the breast |
With the written authority of the Director-General— | ||
Osteoporosis | ||
Patients on long-term treatment with corticosteroids | ||
116 | Nandrolone Phenylpropionate Injection, B.P. | Carcinoma of the breast |
With the written authority of the Director-General— | ||
Osteoporosis | ||
Patients on long-term treatment with corticosteroids | ||
117 | Neomycin Tablets, B.P........................... | Acute leukaemia during induction of remission with chemotherapy |
Bowel sterilization preparatory to major surgery | ||
Encephalopathy, hepatic | ||
Enteropathogenic E. coli infections in infants |
Schedule 5—
Column 1 | Column 2 | Column 3 |
Item | Pharmaceutical benefit | Purpose for which, and the conditions subject to which, the pharmaceutical benefit may be prescribed (including any restrictions as to the persons for whose treatment it may be prescribed) for supply under Part VII of the Act |
118 | Nicotinic Acid Tablets, B.P. | Any disease or condition in a pensioner |
119 | (1) Nitrofurantoin Oral Suspension |
|
(2) Nitrofurantoin Tablets, B.P. | ||
120 | Norethisterone Acetate, B.P., Tablets, 10 mg | Carcinoma of the breast |
Carcinoma of the endometrium | ||
121 | Norethisterone Acetate, B.P., Tablets, 2.5 mg | Endometriosis |
Metropathia haemorrhagica | ||
Precocious puberty | ||
Turner’s syndrome | ||
122 | Norethisterone Tablets, B.P., 5 mg | Benign mammary dysplasia |
Endometriosis | ||
Metropathia haemorrhagica | ||
Precocious puberty | ||
Turner’s syndrome | ||
123 | Orphenadrine Hydrochloride Tablets, B.P. | Parkinsonism |
124 |
| Idiopathic hypertrophic subaortic stenosis |
Right ventricular outflow tract obstruction | ||
Dissecting aneurysm (aortic) | ||
| ||
Serious arrhythmias | ||
Thyrotoxicosis | ||
125 | Oxprenolol Tablets, B.P.......................... | Dissecting aneurysm (aortic) |
Hypertension | ||
Idiopathic hypertrophic subaortic stenosis | ||
Right ventricular outflow tract obstruction | ||
Serious arrhythmias | ||
The treatment of angina in a patient who is frequently disabled by attacks of angina, in whom no evidence of cardiac failure is found | ||
Thyrotoxicosis | ||
126 |
| Treatment in malignant neoplasia |
127 |
| With the written authority of the Director-General— |
Proven aplastic anaemias | ||
Myelosclerosis | ||
128 | (1) Pancreatin, B.P. | Cystic fibrosis (mucoviscidosis) |
(2) Pancreatin Enzyme 4X U.S.N.F.XIII strength | Following pancreatico-duodenectomy | |
Pancreatic steatorrhoea | ||
(3) Pancrelipase | ||
129 | (1) Paraffin Liquid Emulsion | Any disease or condition in a paraplegic or quadriplegic patient |
(2) Paraffin Liquid Emulsion with Phenolphthalein | ||
| ||
130 | (1) Penicillamine Capsules, B.P. | With the written authority of the Director-General— |
Acute heavy metal intoxication | ||
(2) Penicillamine B.P. Tablets, | Cystinosis | |
Cystinuria with calculus formation | ||
Haemoglobinuria, paroxysmal cold | ||
Wilson’s disease (hepatolenticular degeneration) |
Schedule 5
Column 1 | Column 2 | Column 3 |
Item | Pharmaceutical benefit | Purpose for which, and the conditions subject to which, the pharmaceutical benefit may be prescribed (including any restrictions as to the persons for whose treatment it may be prescribed) for supply under Part VII. of the Act |
131 | Pericyazine................................................ | Any disease or condition in a patient receiving treatment in or at an approved hospital |
Chorea | ||
Hyperactive states of organic or toxic delirium | ||
Major psychoses, including— | ||
Major organic psychoses including arteriopathic dementia | ||
Manic-depressive psychosis | ||
Paranoid states | ||
Schizophrenia | ||
Senile dementia | ||
Malignant neoplasia (late stage) | ||
Radiation sickness | ||
Severe conduct disorders in patients who have not attained the age of 16 years | ||
132 | Phenelzine Tablets, B.P........................... | Depressive illness resistant to treatment with tricyclic antidepressants or electro-compulsive therapy |
Obsessive compulsive neurosis | ||
133 | (1) Phenformin Hydrochloride, B.P. |
|
(2) Phenformin Tablets, B.P. | ||
134 | Phenobarbitone Tablets, B.P. | Epilepsy |
135 | Pindolol Injection.................................... | Dissecting aneurysm (aortic) |
Idiopathic hypertrophic subaortic stenosis | ||
Right ventricular outflow tract obstruction | ||
Serious arrhythmias | ||
The treatment of angina in a patient who is frequently disabled by attacks of angina, in whom no evidence of cardiac failure is found | ||
Thyrotoxicosis | ||
136 | Pindolol Tablets....................................... | Dissecting aneurysm (aortic) |
Hypertension | ||
Idiopathic hypertrophic subaortic stenosis | ||
Right ventricular outflow tract obstruction | ||
Serious arrhythmias | ||
The treatment of angina in a patient who is frequently disabled by attacks of angina, in whom no evidence of cardiac failure is found | ||
Thyrotoxicosis | ||
137 | Pizotifen Malate....................................... | Prevention of migraine |
138 | (1) “ PK AID I ”....................................... | Phenylketonuria |
(2) “ PK AID II ” | ||
139 | Polyisobutylene........................................ | Ileostomy or colostomy conditions |
140 | Polyoestradiol Phosphate | Carcinoma of the breast |
Carcinoma of the prostate | ||
141 | Polyvinylpyrrolidone and Vinyl Acetate Copolymer | Ileostomy or colostomy conditions |
142 | Prazosin Hydrochloride........................... | Supplementing beta-blockade in the treatment of hypertension |
143 | (1) Prednisolone Acetate Injection | Local intra-articular or peri-articular infiltration |
(2) Prednisolone Tertiarybutylacetate Injection | ||
144 | Prednisolone Acetate with Phenylephrine Hydrochloride, B.P. | Corneal grafts |
Uveitis |
Schedule 5—
Column 1 | Column 2 | Column 3 |
Item | Pharmaceutical benefit | Purpose for which, and the conditions subject, to which, the pharmaceutical benefit may be prescribed (including any restrictions as to the persons for whose treatment it may be prescribed) for supply under Part, VII. of the Act |
145 |
| Ulcerative colitis |
Proctitis | ||
146 | “ PREGESTIMIL ”.............................. | With the written authority of the Director-General— |
Cystic fibrosis | ||
Multiple disaccharidase deficiency | ||
147 | Propranolol Injection, B.P.................. | Dissecting aneurysm (aortic) |
Idiopathic hypertrophic subaortic; stenosis | ||
Right ventricular outflow tract obstruction | ||
Serious arrhythmias | ||
| ||
Thyrotoxicosis | ||
148 | (1) Propranolol Tablets, B.P., 10 mg and 40 mg | Benign essential tremor (not Parkinsonian tremor). |
Dissecting aneurysm (aortic) | ||
Hypertension | ||
Idiopathic hypertrophic subaortic stenosis | ||
Right ventricular outflow tract obstruction | ||
Serious arrhythmias | ||
| ||
Thyrotoxicosis | ||
(2) Propranolol Tablets, B.P., 160 mg | With the written authority of the Director-General— | |
| ||
| ||
149 | “ PROSOBEE ”....................................... | With the written authority of the Director-General— |
| ||
Galactosaemia | ||
Homocystinuria | ||
Lactose intolerance | ||
150 | Pyridoxine Hydrochloride Tablets | Anaemia proved to be responsive to pyridoxine |
Convulsions responsive to pyridoxine | ||
Homocystinuria | ||
Primary hyperoxaluria | ||
Radiation sickness | ||
Sideroblastic (refractory) anaemia | ||
| ||
151 | Riboflavine Tablets................................. | Any disease or condition in a pensioner |
152 | “ SOBEE ”................................................ | With the written authority of the Director-General— |
| ||
Galactosaemia | ||
Homocystinuria | ||
Lactose intolerance | ||
153 |
| Ileostomy or colostomy conditions |
154 | Sodium Fusidate...................................... |
|
|
Schedule 5—
Column 1 | Column 2 | Column 3 |
Item | Pharmaceutical benefit | Purpose for which, and the conditions subject to which, the pharmaceutical benefit may be prescribed (including any restrictions as to the persons for whose treatment it may be prescribed) for supply under Part VII of the Act |
155 | Sodium Nitroprusside for infusion | For use in a hospital |
156 | “ SOYALAC ”.......................................... | With the written authority of the Director-General— |
| ||
Galactosaemia | ||
Homocystinuria | ||
Lactose intolerance | ||
157 | Spironolactone Tablets, B.P. |
|
Myasthenia gravis | ||
Primary hyperaldosteronism | ||
Secondary hyperaldosteronism | ||
158 | Stanolone Tablets, B.P............................ | Carcinoma of the breast |
With the written authority of the Director-General— | ||
Osteoporosis | ||
Patients on long-term treatment with corticosteroids | ||
159 | Sterculia..................................................... | Ileostomy or colostomy conditions |
160 | Stilboestrol Diphosphate........................ | Carcinoma of the prostate |
161 | Streptokinase, B.P.................................... |
|
162 | (1) Surgical Cement................................ | Any disease or condition in a paraplegic or quadriplegic patient |
(2) Surgical Cement Solvent | ||
For use with surgical appliances | ||
Ileostomy or colostomy conditions | ||
163 | (1) Testosterone Enanthate.................... | Carcinoma of the breast |
(2) Testosterone Propionate Injection, B.P. | Hypogonadism | |
Klinefelter’s syndrome (seminiferous tubule dysgenesis) | ||
164 |
| Carcinoma of the breast |
Gigantism | ||
Hypogonadism | ||
Klinefelter’s syndrome (seminiferous tubule dysgenesis) | ||
| ||
165 | Tetracosactrin Acetate, B.P. | With the written authority of the Director-General— |
Hypsarrhythmia | ||
Multiple sclerosis, acute exacerbation | ||
Status asthmaticus | ||
| ||
| ||
| ||
166 | Tetracosactrin Zinc Injection, B.P. | With the written authority of the Director-General— |
Hypsarrhythmia | ||
Multiple sclerosis, acute exacerbation | ||
Status asthmaticus | ||
| ||
| ||
|
Schedule 5—
Column 1 | Column 2 | Column 3 |
Item | Pharmaceutical benefit | Purpose for which, and the conditions subject to which, the pharmaceutical benefit may be prescribed (including any restrictions as to the persons for whose treatment it may be prescribed) for supply under Part VII. of the Act |
167 | Thiamine Hydrochloride Tablets, B.P. | In or at an approved hospital |
168 | Thioguanine.............................................. | Leukaemia |
169 | Thiopropazate Hydrochloride | Chorea |
Drug induced dystonias | ||
170 | (1) Thioridazine Hydrochloride, B.P. |
|
(2) Thioridazine Tablets, B.P. | Chorea | |
Hyperactive states of organic or toxic delirium | ||
Major psychoses including— | ||
Major organic psychoses including arteriopathic dementia | ||
Manic-depressive psychosis | ||
Paranoid states | ||
Schizophrenia | ||
Senile dementia | ||
Malignant neoplasia (late stage) | ||
Radiation sickness | ||
| ||
171 | Tobramycin Sulphate.............................. | With the written authority of the Director-General— |
| ||
Septicaemia, suspected or proven | ||
172 | Tranylcypromine Tablets, B.P. |
|
Obsessive compulsive neurosis | ||
173 | Triamcinolone Acetonide Injection | Alopecia areata |
Granulomata, dermal | ||
Keloid | ||
Lichen planus hypertrophic | ||
Lichen simplex chronicus | ||
Lupus erythematosus, chronic discoid |
Necrobiosis lipoidica | ||
174 | (1) Trifluoperazine Hydrochloride, B.P. |
|
(2) Trifluoperazine Tablets, B.P. | Chorea | |
Hyperactive states of organic or toxic delirium | ||
Major psychoses including— | ||
Major organic psychoses including arteriopathic dementia | ||
Manic-depressive psychosis | ||
Paranoid states | ||
Schizophrenia | ||
Senile dementia | ||
Malignant neoplasia (late stage) | ||
Radiation sickness | ||
| ||
175 | “ TRIGLYDE ”........................................ |
|
With the written authority of the Director-General, proven malabsorption | ||
176 | Trioxysalen............................................... | Vitiligo |
177 | Vancomycin Hydrochloride................... |
|
178 | Verapamil Hydrochloride....................... | Cardiac arrhythmias |
Schedule 5—
Column 1 | Column 2 | Column 3 |
Item | Pharmaceutical benefit | Purpose for which, and the conditions subject to which, the pharmaceutical benefit may be prescribed (including any restrictions as to the persons for whose treatment it may be prescribed) for supply under Part VII. of the Act |
179 | “ ZERODOR ”......................................... | Ileostomy or colostomy conditions |
180 | “ ZOFF ”................................................... |
|
For use with surgical appliances | ||
Ileostomy or colostomy conditions |
Printed by Authority by the Acting Commonwealth Government Printer
0
0
0